+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Guidewires Market Report and Forecast 2023-2031

  • PDF Icon


  • 147 Pages
  • May 2023
  • Region: Global
  • Expert Market Research
  • ID: 5798009
The global Guidewires market value was USD 1.01 billion in 2022, driven by the increasing rising demand for minimally invasive procedures across the globe. The market size is anticipated to grow at a CAGR of 4.40% during the forecast period of 2023-2031 to achieve a value of USD 1.49 billion by 2031.

Guidewires Introduction

Global Guidewires are thin and flexible medical devices that are used to guide or navigate through arteries, veins, and other pathways inside the body. These wires are commonly made of stainless steel, nitinol, and other materials and come in a variety of sizes and shapes, depending on their intended use.

Guidewires are an essential tool in many diagnostic and therapeutic procedures, such as angioplasty, stenting, and embolization. They help to guide catheters and other medical devices through the body's vascular system with precision and accuracy.

The global guidewire market is expected to experience significant growth in the coming years, driven by factors such as an increasing prevalence of chronic diseases, rising demand for minimally invasive procedures, and technological advancements in guidewire design and materials. The Asia-Pacific region is expected to see the highest growth rate due to the increasing demand for minimally invasive procedures and improving healthcare infrastructure. The growing geriatric population and rising healthcare expenditure are also expected to contribute to market growth.

Guidewires Market Scenario

Global guidewires refer to thin and flexible wires that are used in a variety of medical procedures to navigate through the body's internal pathways, such as blood vessels and the urinary tract. They are essential tools for interventional radiologists, cardiologists, and urologists, among others. Guidewires are made of materials such as stainless steel, nitinol, and tungsten, and come in various lengths, widths, and shapes, depending on the specific procedure being performed.

The global guidewires market is growing due to an increase in the number of minimally invasive procedures being performed, as well as a rise in the incidence of chronic diseases that require diagnostic and therapeutic interventions. Advancements in guidewire technology, such as improved manoeuvrability and durability, are also driving market growth.

The market is highly competitive, with several established players, such as Boston Scientific Corporation, Abbott Laboratories, and Medtronic, as well as many small and medium-sized companies. The market is also segmented based on the type of guidewire, application, and geography.

Guidewires Market Segmentations

Market by Breakup Product Type

  • Surgical Guidewire
  • Diagnostic Guidewires

Market Breakup by Material Type

  • Nitinol Guidewires
  • Stainless Steel Guidewires
  • Hybrid Guidewires
  • Others

Market Breakup by Coating Type


  • Hydrophilic
  • Hydrophobic
  • Non-Coated

Market Breakup by Applications

  • Cardiology, Vascular
  • Neurology
  • Urology
  • Gastroenterology
  • Oncology
  • Otolaryngology
  • Others

Market Breakup by End User

  • Hospitals
  • Diagnostic Centers
  • Surgical Centers
  • Ambulatory Care Centers
  • Research Laboratories
  • Academic Institutes
  • Others

Market Breakup by Region

North America

  • United States of America
  • Canada


  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Key Trends in the Guidewires Market

Some key trends in the global guidewires market are:
  • Rising prevalence of chronic diseases: The increasing incidence of chronic diseases such as cardiovascular diseases, neurovascular disorders, and urological diseases is driving the demand for guidewires
  • Technological advancements: The introduction of technologically advanced guidewires such as nitinol-based guidewires and hybrid guidewires is expected to boost market growth
  • Increasing geriatric population: The aging population is more prone to chronic diseases, which is driving the demand for guidewires in various diagnostic and therapeutic procedures
  • Growing demand for minimally invasive procedures: There is a growing preference for minimally invasive procedures that require guidewires, as they offer benefits such as faster recovery time and reduced pain and scarring
  • Rising demand for disposable guidewires: The demand for disposable guidewires is increasing due to their convenience and cost-effectiveness compared to reusable guidewires
  • Strategic collaborations and partnerships: Key players in the market are entering into strategic collaborations and partnerships to expand their product portfolio and strengthen their market presence

Guidewires Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • Fédération Équestre Internationale
  • Helmer Scientific Inc
  • Boekel Scientific
  • BioCision
  • Cardinal Health
  • Thermo Fisher Scientific, Inc
  • Bioline India
  • LABCOLD, Abbott
  • Medtronic
  • Brainlab AG
  • Varian Medical Systems, Inc
  • Olympus Corporation
  • ATMOS MedizinTechnik GmbH & Co. KG

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Guidewires Market Overview
3.1 Global Guidewires Market Historical Value (2016-2022)
3.2 Global Guidewires Market Forecast Value (2023-2031)
4 Global Guidewires Market Landscape
4.1 Global Guidewires Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Guidewires Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Applications
4.2.3 Analysis by End User
5 Global Guidewires Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Guidewires Market Segmentation
6.1 Global Guidewires Market by Product Type
6.1.1 Market Overview
6.1.2 Surgical Guidewire
6.1.3 Diagnostic Guidewires
6.2 Global Guidewires Market by Material Type
6.2.1 Market Overview
6.2.2 Nitinol Guidewires
6.2.3 Stainless Steel Guidewires
6.2.4 Hybrid Guidewires
6.2.5 Others
6.3 Global Guidewires Market by Coating Type
6.3.1 Market Overview
6.3.2 Coated Hydrophilic Hydrophobic
6.3.3 Non-Coated
6.4 Global Guidewires Market by Applications
6.4.1 Market Overview
6.4.2 Cardiology, Vascular
6.4.3 Neurology
6.4.4 Urology
6.4.5 Gastroenterology
6.4.6 Oncology
6.4.7 Otolaryngology
6.4.8 Others
6.5 Global Guidewires Market by End User
6.5.1 Market Overview
6.5.2 Hospitals
6.5.3 Diagnostic Centers
6.5.4 Surgical Centers
6.5.5 Ambulatory Care Centers
6.5.6 Research Laboratories
6.5.7 Academic Institutes
6.5.8 Others
6.6 Global Guidewires Market by Region
6.6.1 Market Overview
6.6.2 North America
6.6.3 Europe
6.6.4 Asia Pacific
6.6.5 Latin America
6.6.6 Middle East and Africa
7 North America Guidewires Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Guidewires Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Guidewires Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.6 Australia
9.7 Others
10 Latin America Guidewires Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Guidewires Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.5 Others
17 Supplier Landscape
17.1 Fédération Équestre Internationale
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Helmer Scientific Inc
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Boekel Scientific
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 BioCision
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Cardinal Health
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Thermo Fisher Scientific, Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Bioline India.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 LABCOLD, Abbott
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Medtronic
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Brainlab AG
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Varian Medical Systems, Inc.
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Olympus Corporation
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
17.16 KARL STORZ SE & Co. KG
17.16.1 Financial Analysis
17.16.2 Product Portfolio
17.16.3 Demographic Reach and Achievements
17.16.4 Mergers and Acquisitions
17.16.5 Certifications
17.17 ATMOS MedizinTechnik GmbH & Co. KG
17.17.1 Financial Analysis
17.17.2 Product Portfolio
17.17.3 Demographic Reach and Achievements
17.17.4 Mergers and Acquisitions
17.17.5 Certifications
18 Global Guidewires Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • Fédération Équestre Internationale
  • Helmer Scientific Inc
  • Boekel Scientific
  • Sarstedt AG & Co. Kg
  • Biocision
  • Cardinal Health
  • General Electric Company
  • Thermo Fisher Scientific, Inc.
  • Bioline India.
  • Arcox Tmc Group
  • Labcold, Abbott
  • Medtronic
  • Brainlab AG
  • Varian Medical Systems, Inc.
  • Olympus Corporation
  • Karl Storz Se & Co. Kg
  • Atmos Medizintechnik GmbH & Co. Kg



Table Information